Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 mai 2026 17h31 HE | Source: Robbins LLP

IMMP Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Immutep Limited Class Action Lawsuit

Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug Candidate
08 mai 2026 15h22 HE | Source: Robbins LLP

RGC Investors Have Rights – If You Lost Money Investing in Regencell Bioscience Holdings Limited Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Regencell Bioscience Holdings Limited (RGC) was Impacted by a Stock Manipulation Scheme
08 avr. 2026 20h04 HE | Source: Robbins LLP

MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action lawsuit Filed Against Medpace Holdings Inc.

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
06 avr. 2026 13h17 HE | Source: Robbins LLP

GOSS Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gossamer Bio, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
02 mars 2026 14h51 HE | Source: Robbins LLP

ZYXIQ Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Fraud Class Action on Behalf of Zynex, Inc. Stockholders

Robbins LLP is Investigating Allegations that Zynex, Inc. (ZYXIQ) Filed False Claims and Failed to Comply with Industry Regulations
31 oct. 2025 14h50 HE | Source: Robbins LLP

AVTR Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Avantor, Inc.

Robbins LLP is Investigating Allegations that Avantor, Inc. (AVTR) Mislead Investors Regarding the Effects of Increased Competition
10 oct. 2025 19h24 HE | Source: Robbins LLP

ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.

Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate
12 sept. 2025 16h01 HE | Source: Robbins LLP

SVRA Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Savara Inc. Securities Class Action Lawsuit

Robbins LLP is Investigating Allegations that Savara Inc. (SVRA) Misled Investors About the Viability of its Lead Drug Candidate
02 juin 2025 19h36 HE | Source: American Board of Obstetrics and Gynecology

Clarifying ABOG's Mission and the Certification Process

Dallas, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) acknowledges the perspectives and concerns raised by attorneys general regarding the safety...
29 oct. 2024 10h00 HE | Source: Southern California Biomedical Council

SoCalBio Annual Investor & Partnering Conference Celebrates its 26th Successful Year as Greater Los Angeles’ Biotech/Medtech Industry’s Most Influential Event

LOS ANGELES, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Southern California Biomedical Council (SoCalBio) is proud to conclude the 2024 26th Annual Investor & Partnering Conference in Newport Beach, held...

Page suivante